Company profile: Scopus BioPharma
1.1 - Company Overview
Company description
- Provider of biopharmaceutical therapeutics based on discoveries from leading research and academic institutions, developing targeted immunotherapies for treatment-resistant cancers, including a novel immuno-oncology gene therapy for multiple cancers and DUET-02, a CpG-STAT3 inhibitor part of the Duet Platform targeting malignant glioma.
Products and services
- Lead Drug Candidate (Targeted Immuno-Oncology Gene Therapy): Novel, gene therapy–based immuno-oncology product engineered to treat multiple cancers, capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions
- DUET-02: Platform-based CpG-STAT3 inhibitor targeting malignant glioma as part of the Duet Platform, advancing precisely targeted therapies within oncology
- Targeted Immunotherapies: Targeted immunotherapy products under development aimed at treatment-resistant cancers, creating transformational therapeutics rooted in leading academic research and medical discoveries
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scopus BioPharma
Juva Life
HQ: United States
Website
- Description: Provider of vertically integrated cannabis products and services, overseeing cultivation for proprietary lines and other licensed companies in California, distribution of in-house and third‑party brands, and retail via a flagship storefront and SF Peninsula delivery. Combines research, testing, and efficacy with the JuLi longitudinal study, offering Rosin Absolute vape and an Infused Flower Line for enhanced potency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Juva Life company profile →
Agritek Holdings
HQ: United States
Website
- Description: Provider of technology and agricultural solutions for the cannabis industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agritek Holdings company profile →
American Cannabis Company
HQ: United States
Website
- Description: Provider of industry-specific advisory and consulting for recreational and medical cannabis and commercial hemp, including strategic planning, financial modeling, business planning, conceptual design, and application services; operational and cultivation management; ACC brand licensing; acquisitions and equity partnerships; and manufacturing cultivation products and facilities for startups, serving domestic and international markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full American Cannabis Company company profile →
Rimrock Gold
HQ: United States
Website
- Description: Provider of CBD products, including CBD oils, and hemp extract services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rimrock Gold company profile →
APIRx
HQ: United States
Website
- Description: Provider of cGMP cannabinoid APIs based on naturally extracted cannabinoids, and cannabinoid-infused products including CBD pet food, wellness gum, CBD roll-on sticks, cannabinoid suppositories, and cannabinoid chewing gum potentially combined with other active ingredients like nicotine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full APIRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scopus BioPharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scopus BioPharma
2.2 - Growth funds investing in similar companies to Scopus BioPharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scopus BioPharma
4.2 - Public trading comparable groups for Scopus BioPharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →